Research Article

Interactions between Serum Adipokines and Osteocalcin in Older Patients with Hip Fracture

Table 3

Associations of serum adipokine ratios with serum osteocalcin as dependent variable in linear regression models.

AdjustmentsLeptin/Adiponectin ratioLeptin/Resistin ratioAdiponectin/Resistin ratio
βPβPβP

Unadjusted0.0370.0410.0550.0080.0470.098
+Age, sex, BMI0.0480.0070.0790.0000.0440.114
+HF type0.0480.0080.0790.0000.0440.115
+25(OH)D0.0390.0280.0710.0010.0450.095
+PTH0.0420.0190.0750.0000.0480.076
+Ca, Mg, PO40.0410.0230.0680.0020.0480.084
+eGFR0.0310.0740.0570.0070.0520.042
+Haemoglobin0.0330.0640.0610.0050.0520.043
+type 2 DM0.0340.0550.0580.0060.0350.426
+Hypertension*0.0340.0600.0610.0050.0530.044
+CVD (any)*0.0340.0620.0600.0050.0510.050
+CVD (any)0.0340.0570.0570.0090.0380.453

Osteocalcin was included in the models as a logarithmically transformed variable. +indicates adjustments for all covariates in the above model; *Indicates adjustments for all covariates in the above model except type 2 DM; β standard regression coefficient; P probability value; DM, diabetes mellitus; CVD, cardiovascular disease; BMI, body mass index; HF, hip fracture; 25(OH)D, 25 hydroxy vitamin D; PTH, parathyroid hormone; Ca, calcium; Mg, magnesium; PO4, phosphate; eGFR, estimated glomerular filtration rate.